x
Visit our new Mobile Website next time you access NetDania with your mobile device

PROTAGONIST THERAPEUTICS INC. - COMMON STOCK

27.11
08-19:59:58 GMT
+1.32
+5.12%
ISIN:N/A

Figures - PROTAGONIST THERAPEUTICS INC. - COMMON STOCK

Open
27.08
Close
25.79
Year Change
18.23
Year % Change
+18.23%
52 Week High
33.34
52 Week Low
13.72
Volume
774643
Inc. Vol
95051

News - PROTAGONIST THERAPEUTICS INC. - COMMON STOCK

08-21:45 GMT
Shopify in 'penalty box' but still in the game after shares drop: Greg Taylor
Source: FinancialPost-TopStories, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:42 GMT
Up 16% YTD, This Russell 2000 Energy Stock Still Looks Cheap
Source: NASDAQ Stocks, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:35 GMT
Watch: US and allies sink mock enemy ship in military drill
Source: BBC US-Canada, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:34 GMT
5 Of The Best Oil And Gas Stocks To Buy For High Crude Prices
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:34 GMT
Marjorie Taylor Greene Triggers Motion To Vacate Vote On Removing Speaker Mike Johnson
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:33 GMT
‘Dark Matter’ Helped Joel Edgerton Realize He Wouldn’t Change A Thing
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:33 GMT
Today’s NYT ‘Connections’ Hints And Answers For Thursday, May 9
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
Why Did the iShares Bitcoin Trust Drop 17% in April?
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
Horace Mann Educators Q1 Profit Increases, but misses estimates
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
CoreCivic Inc Q1 Profit Decreases, but beats estimates
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
Beyond Meat, Inc. Q1 Loss Decreases, but misses estimates
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
Black Hills Corp Profit Advances In Q1, Beats estimates
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
Atmos Energy Corporation Reveals Increase In Q2 Profit, Beats estimates
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
Equinix Q1 AFFO Rises
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
MannKind Corp. Q1 Earnings Summary
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
STERIS plc Q4 Earnings Summary
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
P10, Inc. Q1 Income Advances
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
Manulife Financial Q1 Profit Retreats
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:25 GMT
A Conversation With Nomzamo Mbatha | Forbes Under30 Africa Summit 2024
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:24 GMT
RFK Jr. Says A Worm Infected His Brain—Here's What We Know About The Possible Parasite
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:21 GMT
08-21:19 GMT
InnovationRx: Deepmind Unveils Its New Protein-Folding AI Model AlphaFold 3
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:18 GMT
Raising Money: What VCs Are Looking For In Africa Now | Forbes Under30 Africa Summit 2024
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:16 GMT
Crude Prices Finish Higher After Weekly EIA Inventories Decline
Source: NASDAQ Stocks, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:16 GMT
Nat-Gas Prices Undercut by Abundant US Supplies
Source: NASDAQ Stocks, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:13 GMT
Spotlight: Optimizing Your Talents For Success | Forbes Under30 Africa Summit 2024
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:06 GMT
Globalizing African Music And Languages | Forbes Under30 Africa Summit 2024
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-21:02 GMT
Financing Impactful Solutions | Forbes Under30 Africa Summit 2024
Source: Forbes World, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-20:59 GMT
Karyopharm Therapeutics (KPTI) Q1 2024 Earnings Call Transcript
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
08-20:59 GMT
iRhythm Technologies (IRTC) Shares Cross Below 200 DMA
Source: NASDAQ US Markets, Symbol: PROTAGONIST THERAPEUTICS INC. - COMMON STOCK
Five Star Chart – Build your favorite menu, 100+ studies, for mobile and desktop
Find a Top Broker
Global
Forex
39070.27
195.03
0.50%
5187.79
-1.1
-0.02%
18069.18
-33.93
-0.19%
61592.00
-842
-1.35%
18563.75
66.24
0.36%
38391.87
-334.99
-0.87%
3128.48
-19.26
-0.61%
8386.11
31.66
0.38%
18354.99
-130.36
-0.71%
7794.68
-14.28
-0.18%
22302.50
0
0.00%
2308.50
-6.65
-0.29%
83.74
0.67
0.81%
1.07478
-0.00019
-0.02%
155.486
0.714
0.46%
1.24958
-0.00058
-0.05%
0.65774
-0.0011
-0.17%
1.37223
-0.00109
-0.08%
167.12700
0.747
0.45%
0.86000
0.00015
0.02%
194.29200
0.803
0.42%
0.90773
-0.00072
-0.08%
0.97562
-0.00106
-0.11%
0.60044
0.00081
0.14%
105.50900
0.13
0.12%
Top Gainers
Name
Last
+/-
%
0.24
0.14
136.28%
3.19
1.46
84.39%
0.06
0.02
65.71%
0.62
0.23
58.81%
0.05
0.02
57.05%
10.47
3.73
55.34%
0.20
0.07
51.36%
8.14
2.61
47.20%
0.06
0.02
45.00%
2.14
0.64
42.67%
Top Losers
Name
Last
+/-
%
4.17
-6.95
-62.50%
0.08
-0.10
-56.34%
0.02
-0.01
-40.13%
0.04
-0.03
-37.68%
0.01
0.00
-36.19%
0.00
0.00
-35.71%
0.04
-0.02
-34.72%
0.03
-0.02
-34.49%
0.02
-0.01
-32.92%
0.26
-0.13
-32.60%
NetDania does not guarantee the accuracy of data contained on this website, nor do we guarantee that data is real-time. Data on this website may be provided from OTC market sources and market makers, and not necessarily from exchanges. The provided price data is indicative and may not be appropriate for trading or decision making purposes. NetDania does not assume any responsibility for any losses incurred from the use of the provided data.
NetDania does not endorse or promote any broker or financial service. NetDania is a pure technology provider offering its software with broker integration. Any user of NetDania software must be an existing client of one of our supported brokers. NetDania showcases NetDania technology for the purpose of demonstrating it towards brokers and other institutions looking to white label the technology on a software subscription contract. No financial services are offered, promoted or recommended. NetDania is compensated as a technology provider by its institutional clients including its integrated brokers. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation affecting it.

Persons or entities including approved brokers not belonging to the NetDania Group may advertise on the NetDania and its Group’s websites, through links, banners or otherwise. We have not taken any steps to verify the accuracy, quality or reliability of any products, information or services provided by third parties that have links on our website. We accordingly provide no warranties with regard to and disclaim responsibility for any such products, information or services and exclude all liability in this regard to the fullest extent permitted by relevant laws and regulations. If a user of the NetDania Group’s websites decides to act upon any such advertising, such user does so entirely at its own risk.

NetDania’s website may be accessed worldwide. The Information provided on its website is however only intended for use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. None of the offerings services referred to on this website are available to recipients residing in countries where the provision of such offerings would constitute a violation of mandatory applicable legislation or regulations. It is the sole responsibility of any recipient employing or requesting an offering to comply with all applicable legislation or regulation.

HIGH RISK INVESTMENT WARNING:
End-users of the NetDania software that make use of the trading integration features as direct clients of integrated brokers, should be aware of the level of risk carried by trading in financial markets. Trading foreign exchange and or other financial instruments on margin carries a high level of risk, and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or more of your initial investment, and therefore you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading, and seek advice from your broker and or an independent financial advisor if you have any doubts. Anyone opening a live trading account needs to adhere to the laws of their local country as such laws may differ from country to country.
NetDania expressly disclaims any liability for any lost principal or profits which without limitation may arise directly or indirectly from the use of or reliance on information on our website or the use of our software with broker integration.
Copyright © 1998 -2024 NetDania Creations ApS, Holmens Kanal 7, 1060 Copenhagen K, Denmark, +4536988200, Contact NetDania by email, CVR-nr.27976670 Terms And Conditions and Privacy Policy